1 research outputs found
Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma.
Daratumumab showed promising efficacy alone and with lenalidomide and dexamethasone in a phase 1-2 study involving patients with relapsed or refractory multiple myeloma.info:eu-repo/semantics/publishe